Table 3 Characteristics of patients with COVID-19 who died (n = 15) in hospital or survived (n = 95)
In-hospital outcome | P (Chi-square analysis) | |||||
|---|---|---|---|---|---|---|
Survived | Deceased | |||||
Count | % | Count | % | |||
Age (years) | Lowk | 53 | 56 | 3 | 20 | = 0.01 |
(median) | Highl | 42 | 44 | 12 | 80 | |
Creatinine (µmol/l) (median) | Low | 56 | 59 | 3 | 20 | < 0.01 |
High | 39 | 41 | 12 | 80 | ||
eGFRa (ml/min/1.73m2) median | Low | 44 | 46 | 12 | 80 | < 0.05 |
High | 51 | 54 | 3 | 20 | ||
WBCb count (x10i/l) (median) | Low | 52 | 55 | 2 | 13 | < 0.01 |
High | 43 | 45 | 13 | 87 | ||
Neutrophil count (x10i/l) (median) | Low | 46 | 48 | 3 | 20 | < 0.05 |
High | 49 | 52 | 12 | 80 | ||
Lymphocyte count (x10i/l) (median) | Low | 42 | 44 | 9 | 60 | NS |
High | 53 | 56 | 6 | 40 | ||
NLRc (median) | Low | 46 | 48 | 2 | 13 | = 0.01 |
High | 49 | 52 | 13 | 87 | ||
CRPd (mg/l) (median) | Low | 51 | 54 | 3 | 20 | < 0.05 |
High | 44 | 46 | 12 | 80 | ||
B cell modulation | ||||||
BAFFe (pg/ml) (median) | Low | 52 | 55 | 3 | 20 | = 0.01 |
High | 43 | 45 | 12 | 80 | ||
IL-4f (pg/ml) (median) | Low | 50 | 53 | 5 | 33 | NS |
High | 45 | 47 | 10 | 67 | ||
IFN- αg (pg/ml) (median) | Low | 50 | 53 | 4 | 27 | 0.06 |
High | 45 | 47 | 11 | 73 | ||
T cell modulation | ||||||
sCD25h/IL-2Rαi (pg/ml) (median) | Low | 53 | 56 | 2 | 13 | < 0.01 |
High | 42 | 44 | 13 | 87 | ||
sCD40L (pg/ml) (median) | Low | 48 | 51 | 7 | 47 | NS |
High | 47 | 49 | 8 | 53 | ||
sPD-L1j (pg/ml) (median) | Low | 51 | 54 | 4 | 27 | 0.052 |
High | 44 | 46 | 11 | 73 | ||
sCD95/Fas (pg/ml) (median) | Low | 51 | 54 | 4 | 27 | 0.052 |
High | 44 | 46 | 11 | 73 | ||